SurePathTM technology, using 3D cluster patterns and dual ICC for CK7 and PAX8 in peritoneal fluid samples, can provide important information for determining specific primary origins in cases of unknown primary carcinoma. The gene discussed is KRT7; the disease is intrahepatic cholangiocarcinoma.